Pfizer Inc. (PFE) reported fourth-quarter net income attributable to the company of $767 million or $0.10 per share, compared to net income of $266 million or $0.04 per share in the same quarter last year.
On an adjusted basis, net income was $3.83 billion or $0.49 per share, compared to net income of $4.39 billion or $0.65 per share in the year ago quarter. Analysts polled by Thomson Reuters expected the company to report earnings of $0.50 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues for the quarter were $16.54 billion, up from $12.35 billion in the comparable quarter last year. Thirteen analysts had consensus revenue estimate of $15.88 billion for the quarter.
For fiscal 2010, the company expects reported earnings per share to be in the range of $0.95 to $1.10, and adjusted earnings per share to be in the range of $2.10 to $2.20. Reported revenues are expected to be between $67.0 billion and $69.0 billion. Analysts expect the company to report earnings of $2.27 per share on revenues of $67.47 billion for fiscal 2010. Analysts' estimates typically exclude special items.
For 2012, at current exchange rates, Pfizer is targeting reported revenue between $66.0 billion to $68.5 billion, reported EPS between $1.58 and $1.73 and adjusted EPS between $2.25 and $2.35.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.